Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Matching tumor risk with aggressiveness of treatment in men with multiple comorbidities and early-stage prostate cancer.

Daskivich TJ, Chamie K, Kwan L, Dash A, Greenfield S, Litwin MS.

Cancer. 2013 Oct 1;119(19):3446-53. doi: 10.1002/cncr.28226. Epub 2013 Jul 16.

PMID:
23861016
[PubMed - indexed for MEDLINE]
2.

Comorbidity and competing risks for mortality in men with prostate cancer.

Daskivich TJ, Chamie K, Kwan L, Labo J, Dash A, Greenfield S, Litwin MS.

Cancer. 2011 Oct 15;117(20):4642-50. doi: 10.1002/cncr.26104. Epub 2011 Apr 8.

PMID:
21480201
[PubMed - indexed for MEDLINE]
Free Article
3.

Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer.

Daskivich TJ, Fan KH, Koyama T, Albertsen PC, Goodman M, Hamilton AS, Hoffman RM, Stanford JL, Stroup AM, Litwin MS, Penson DF.

Ann Intern Med. 2013 May 21;158(10):709-17. doi: 10.7326/0003-4819-158-10-201305210-00005.

PMID:
23689764
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Overtreatment of men with low-risk prostate cancer and significant comorbidity.

Daskivich TJ, Chamie K, Kwan L, Labo J, Palvolgyi R, Dash A, Greenfield S, Litwin MS.

Cancer. 2011 May 15;117(10):2058-66. doi: 10.1002/cncr.25751. Epub 2010 Nov 29.

PMID:
21523717
[PubMed - indexed for MEDLINE]
Free Article
5.

Comparative effectiveness of aggressive versus nonaggressive treatment among men with early-stage prostate cancer and differing comorbid disease burdens at diagnosis.

Daskivich TJ, Lai J, Dick AW, Setodji CM, Hanley JM, Litwin MS, Saigal C; Urologic Diseases in America Project.

Cancer. 2014 Aug 15;120(16):2432-9. doi: 10.1002/cncr.28757. Epub 2014 May 13.

PMID:
24824511
[PubMed - indexed for MEDLINE]
6.

Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysis.

Briganti A, Spahn M, Joniau S, Gontero P, Bianchi M, Kneitz B, Chun FK, Sun M, Graefen M, Abdollah F, Marchioro G, Frohenberg D, Giona S, Frea B, Karakiewicz PI, Montorsi F, Van Poppel H, Jeffrey Karnes R; European Multicenter Prostate Cancer Clinical and Translational Research Group (EMPaCT).

Eur Urol. 2013 Apr;63(4):693-701. doi: 10.1016/j.eururo.2012.08.054. Epub 2012 Sep 5.

PMID:
22959192
[PubMed - indexed for MEDLINE]
7.

Prediction of Long-term Other-cause Mortality in Men With Early-stage Prostate Cancer: Results From the Prostate Cancer Outcomes Study.

Daskivich TJ, Fan KH, Koyama T, Albertsen PC, Goodman M, Hamilton AS, Hoffman RM, Stanford JL, Stroup AM, Litwin MS, Penson DF.

Urology. 2015 Jan;85(1):92-100. doi: 10.1016/j.urology.2014.07.003. Epub 2014 Sep 26.

PMID:
25261048
[PubMed - in process]
8.

Comorbidities, treatment and ensuing survival in men with prostate cancer.

Chamie K, Daskivich TJ, Kwan L, Labo J, Dash A, Greenfield S, Litwin MS.

J Gen Intern Med. 2012 May;27(5):492-9. doi: 10.1007/s11606-011-1869-4. Epub 2011 Sep 21.

PMID:
21935751
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based study.

Rider JR, Sandin F, Andrén O, Wiklund P, Hugosson J, Stattin P.

Eur Urol. 2013 Jan;63(1):88-96. doi: 10.1016/j.eururo.2012.08.001. Epub 2012 Aug 10.

PMID:
22902040
[PubMed - indexed for MEDLINE]
10.

Five-year downstream outcomes following prostate-specific antigen screening in older men.

Walter LC, Fung KZ, Kirby KA, Shi Y, Espaldon R, O'Brien S, Freedland SJ, Powell AA, Hoffman RM.

JAMA Intern Med. 2013 May 27;173(10):866-73. doi: 10.1001/jamainternmed.2013.323.

PMID:
23588999
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: a population-based analysis.

Abdollah F, Schmitges J, Sun M, Jeldres C, Tian Z, Briganti A, Shariat SF, Perrotte P, Montorsi F, Karakiewicz PI.

Int J Urol. 2012 Sep;19(9):836-44. doi: 10.1111/j.1442-2042.2012.03052.x. Epub 2012 May 10.

PMID:
22574746
[PubMed - indexed for MEDLINE]
12.

Improved prediction of long-term, other cause mortality in men with prostate cancer.

Daskivich TJ, Chamie K, Kwan L, Labo J, Dash A, Greenfield S, Litwin MS.

J Urol. 2011 Nov;186(5):1868-73. doi: 10.1016/j.juro.2011.07.033. Epub 2011 Sep 23.

PMID:
21944092
[PubMed - indexed for MEDLINE]
13.

Causes of mortality after dose-escalated radiation therapy and androgen deprivation for high-risk prostate cancer.

Tendulkar RD, Hunter GK, Reddy CA, Stephans KL, Ciezki JP, Abdel-Wahab M, Stephenson AJ, Klein EA, Mahadevan A, Kupelian PA.

Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):94-9. doi: 10.1016/j.ijrobp.2013.05.044.

PMID:
23920389
[PubMed - indexed for MEDLINE]
14.

Impact of comorbidity on survival among men with localized prostate cancer.

Albertsen PC, Moore DF, Shih W, Lin Y, Li H, Lu-Yao GL.

J Clin Oncol. 2011 Apr 1;29(10):1335-41. doi: 10.1200/JCO.2010.31.2330. Epub 2011 Feb 28.

PMID:
21357791
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age.

Sweat SD, Bergstralh EJ, Slezak J, Blute ML, Zincke H.

J Urol. 2002 Aug;168(2):525-9.

PMID:
12131302
[PubMed - indexed for MEDLINE]
16.

Aspects of survival from colorectal cancer in Denmark.

Iversen LH.

Dan Med J. 2012 Apr;59(4):B4428.

PMID:
22459726
[PubMed - indexed for MEDLINE]
17.

Cancer-specific mortality after radiation therapy with short-course hormonal therapy or radical prostatectomy in men with localized, intermediate-risk to high-risk prostate cancer.

Tsai HK, Chen MH, McLeod DG, Carroll PR, Richie JP, D'Amico AV.

Cancer. 2006 Dec 1;107(11):2597-603.

PMID:
17039498
[PubMed - indexed for MEDLINE]
Free Article
18.

Evaluating prostate cancer mortality and competing risks of death in patients with localized prostate cancer using a comprehensive nomogram.

Kutikov A, Cooperberg MR, Paciorek AT, Uzzo RG, Carroll PR, Boorjian SA.

Prostate Cancer Prostatic Dis. 2012 Dec;15(4):374-9. doi: 10.1038/pcan.2012.21. Epub 2012 Jun 19.

PMID:
22710832
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Variation in treatment associated with life expectancy in a population-based cohort of men with early-stage prostate cancer.

Daskivich TJ, Lai J, Dick AW, Setodji CM, Hanley JM, Litwin MS, Saigal C; Urologic Diseases in America Project.

Cancer. 2014 Dec 1;120(23):3642-50. doi: 10.1002/cncr.28926. Epub 2014 Jul 17.

PMID:
25042117
[PubMed - in process]
20.

Survival benefit of radical prostatectomy in patients with localized prostate cancer: estimations of the number needed to treat according to tumor and patient characteristics.

Abdollah F, Sun M, Schmitges J, Thuret R, Bianchi M, Shariat SF, Briganti A, Jeldres C, Perrotte P, Montorsi F, Karakiewicz PI.

J Urol. 2012 Jul;188(1):73-83. doi: 10.1016/j.juro.2012.03.005. Epub 2012 May 12.

PMID:
22578732
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk